Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 I, 1997, Pages 781-788

  Corren, Jonathan ^a   Harris, Alan G ^b   Aaronson, Donald ^c   Beaucher, Wilfred ^d   Berkowitz, Robert ^e   Bronsky, Edwin ^f   Chen, Rongdean ^b   Chervinsky, Paul ^g   Cohen, Robert ^h   Fourre, Jon ^b   Grossman, Jay ⁱ   Meltzer, Eli ^j   Pedinoff, Andrew ^k   Stricker, Wesley ^l   Wanderer, Allen ^m  

^a Allergy Research Foundation   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Allergy and Asthma Drug Study Center   (United States)

^d Certified Allergy Consultants   (United States)

^e Atlanta Allergy and Immunology Research Foundation   (United States)

^f Clinical Research   (United States)

^g Allergy and Asthma Center   (United States)

^h Allergy and Asthma Center   (United States)

ⁱ Allergy Care Consultants Ltd   (United States)

^j ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^k Princeton Allergy and Asthma Associates   (United States)

^l Clinical Research of the Ozarks   (United States)

^m Clin Research Centers of Colorado   (United States)

more..

Author keywords

Albuterol; Asthma; Loratadine; Nasal obstruction; Peak expiratory flow rate; Pseudoephedrine; Quality of life; Rhinitis; Spirometry

Indexed keywords

ANTIHISTAMINIC AGENT; CLARITIN D; DECONGESTIVE AGENT; LORATADINE; PSEUDOEPHEDRINE; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PHARYNGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SUSTAINED RELEASE PREPARATION; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION;

EID: 0031395189     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70274-4     Document Type: Article

References (34)

1. Settipane GA. Allergic rhinitis - update. Otolaryngol Head Neck Surg 1986;94:470-5.
2. Evans R III, Mullally DI, Wilson RW, Gergen PJ, Rosenberg HM, Grauman JS, et al. National trends in the morbidity and mortality of asthma in the U.S.: prevalence, hospitalization, and death from asthma over two decades, 1965-1984. Chest 1987;91:65S-74S.
3. Blair H. Natural history of childhood asthma: 20 year follow-up. Arch Dis Child 1977;52:613-9.
4. Smith JM. Epidemiology and natural history of asthma, allergic rhinitis and atopic dermatitis (eczema). In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, editors. Allergy, principles and practice. 3rd ed. St. Louis: C.V. Mosby Co., 1988. p. 893-4.
5. Yan K, Salome C. The response of the airways to nasal stimulation in asthmatics with rhinitis. Eur J Respir Dis 1983;64:105-8.
6. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992;89:611-8.
7. Shturman-Ellstein R, Zeballos RJ, Buckley JM, Souhrada JF. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis 1978;118:65-73.
8. Griffin MP, McFadden ER, Ingram RH. Airway cooling in asthmatic and nonasthmatic subjects during nasal and oral breathing. J Allergy Clin Immunol 1982;69:354-9.
9. Henriksen JW, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing and asthma. Am Rev Respir Dis 1984;130:1014-8.
10. Welsh PW, Sticker EW, Chu-Pin C, Naessens JM, Reese ME, Reed CE, et al. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987;62:125-34.
11. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90:250-6.
12. Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97-101.
13. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NR Jr, Meyers DA, Norman PS, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
14. Jarjour NN, Calhoun WJ, Schwartz LB, Busse WW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 1991;144:83-7.
15. Dockhorn RJ, Bergner A, Connell JT, Falliers CJ, Grabiec SV, Weiler JM, et al. Safety and efficacy of loratadine (SCH 29851) a new nonsedating antihistamine in seasonal allergic rhinitis. Ann Allergy 1987;58:407-11.
16. Karlin JM. The use of antihistamines in asthma. Ann Allergy 1972;30:342-7.
17. Taytard A, Beaumont D, Pujet JC, Sapene M, Lewis PJ. Treatment of bronchial asthma with terfenadine; a randomized controlled trial. Br J Clin Pharmacol 1987;24:743-6.
18. Rafferty P, Jackson L, Smith R, Holgate ST. Terfenadine, a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma. Br J Clin Pharmacol 1990;30:229-35.
19. Wood-Baker R, Smith R, Holgate ST. A double-blind, placebo controlled study of the effect of the specific histamine H1-antagonist, terfenadine, in chronic severe asthma. Br J Clin Pharmacol 1995;39: 671-5.
20. Bruttman G, Pedrali P, Arendt C, Rihoux JP. Protective effect of cetirizine in patients suffering from pollen asthma. Ann Allergy 1990;64:224-8.
21. Dijkman JH, Hekking PRM, Molkenboer JF, Nierop G, Vanderschueren R, Bernheim J, et al. Prophylactic treatment of grass pollen-induced asthma with cetirizine. Clin Exp Allergy 1990;20:483-90.
22. Grant JA, Nicodemus CF, Findlay SR, Glousky MM, Grossman J, Kaiser H, et al. Cetirizine in patients with seasonal allergic rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.
23. Aaronson DW. Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma. Ann Allergy Asthma Immunol 1996; 76:440-6.
24. Dirksen A, Engel T, Frolund L, Heinig JH, Svendsen UG, Weeke B. Effect of a nonsedative antihistaminic (loratadine) in moderate asthma. Allergy 1989;44:566-71.
25. Bronsky E, Boggs P, Findlay SG, Gawchik S, Georgitis J, Mansmann H, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol 1995;96:139-47.
26. Ware JE, Snow KK, Kosingski M, Gandek B. SF-36 health survey manual and interpretation guide. Boston: The Health Institute; 1993.
27. Marks GB, Dunn SM, Woolcock A. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992;45:461-72.
28. Schering-Plough Corporation, data on file.
29. de Jong JW, Teeng JP. Postma DS, van der Mark TW, Koeler GH, de Monchy JG. Nedocromil sodium versus albuterol in the management of allergic asthma. Am J Respir Crit Care Med 1994;149:91-7.
30. Svendsen UG, Frolund L, Madsen F, Nielsen NH, Holstein-Rathlou NH, Weeke B. A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthma. J Allergy Clin Immunol 1987;80:68-74.
31. Bousquet J, Godard P, Michel FB. Antihistamines in the treatment of asthma. Eur Respir J 1992;5:1137-42.
32. Laitinen LA, Empey DW, Bye C, Britton MG, McDonnell K, Hughes DT. A comparison of the bronchodilator action of pseudoephedrine and ephedrine in patients with reversible airway obstruction. Eur J Clin Pharmacol 1982;23:107-9.
33. Proctor DF. The upper airways. I. Nasal physiology and defense of the lungs. Am Rev Respir Dis 1977;115:97-130.
34. American Academy of Allergy and Immunology Committee on Drugs. The use of antihistamines in asthma. J Allergy Clin Immunol 1988;82:481-2.